Michael Gertner

Consultant
Biodesign Innovation Program
Stanford, CA

Dr. Gertner is currently the President and CEO of Oraya Therapeutics, a venture backed company which he founded in 2006. He is a consultant to the Biodesign Program, to the Department of Surgery at Stanford, and to the Department of Surgery at Santa Clara Valley Medical Center.

Dr. Gertner completed a BS and an MS in mechanical engineering from Columbia and MIT and attended medical school at Cornell. He then attended UCSF through a chief residency in General Surgery. He is currently board certified in general surgery. In addition to Oraya, Dr. Gertner is the founder or co-founder of Medlogics Device Corporation, Allux Medical, Minimus Surgical Systems, Hydrocardia, and Gem Biosystems. He also serves on the board of directors of Stratagent Lifesciences and Nellix Medical.